DISPOSITION OF THIORPHAN IN DOCA-SALT AND SPONTANEOUSLY HYPERTENSIVE RATS

被引:0
|
作者
SAKANE, Y
BERRY, C
HOPKINS, MF
SINGH, K
GHAI, RD
机构
来源
RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY | 1993年 / 81卷 / 02期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Thiorphan was administered intravenously (i. v.) at 10 mg/kg to conscious rats in two different models of hypertension to allow a comparison of pharmacokinetics. The two models were: 1) Deoxycorticosterone acetate (DOCA)-salt uninephrectomized rats; 2) Spontaneously hypertensive rats (SHR), and their respective normotensive controls; 3) Sprague-Dawley (SD) rats; and 4) Wistar-Kyoto rats (WKY). Pharmacokinetic parameters were calculated for total and unbound thiorphan in plasma. In normotensive SD and WKY rats, the volume of distribution, clearance and plasma protein binding of thiorphan were not significantly different. Furthermore, the apparent elimination half-life was not significantly different for total or unbound thiorphan amongst all models. The volume of distribution and plasma clearance for both unbound and total thiorphan, however, were lower in DOCA-salt rats when compared to normotensive control rats by 61-66% and 46-51%, respectively. In contrast, pharmacokinetic parameters for both unbound and total thiorphan were not significantly different between SHR and WKY rats. These results indicate that reduced clearance of thiorphan in DOCA-salt rats may be due to the co-administration of DOCA-salt or altered renal function of the hypertrophic remaining kidney and not solely due to hypertension.
引用
收藏
页码:151 / 158
页数:8
相关论文
共 50 条
  • [41] Different activation of vascular mitogen-activated protein kinases in spontaneously and DOCA-salt hypertensive rats
    Kubo, T
    Ibusuki, T
    Saito, E
    Kambe, T
    Hagiwara, Y
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 400 (2-3) : 231 - 237
  • [42] Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats
    Chan, Vincent
    Hoey, Andrew
    Brown, Lindsay
    BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (07) : 902 - 908
  • [43] Influence of enalapril on the endothelial function of DOCA-salt hypertensive rats
    Nunes, VW
    Fortes, ZB
    Nigro, D
    Carvalho, MHC
    Zorn, TMT
    Scivoletto, R
    GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 2000, 34 (02): : 117 - 125
  • [44] PARTICIPATION OF THE NUCLEUS LOCUS COERULEUS IN DOCA-SALT HYPERTENSIVE RATS
    CHIDA, K
    KAWAMURA, H
    HATANO, M
    BRAIN RESEARCH, 1983, 273 (01) : 53 - 58
  • [45] Resveratrol Improves Cardiovascular Function in DOCA-Salt Hypertensive Rats
    Chan, Vincent
    Fenning, Andrew
    Iyer, Abishek
    Hoey, Andrew
    Brown, Lindsay
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (03) : 429 - 436
  • [46] Antihypertensive, effect of a proteasome inhibitor in DOCA-salt hypertensive rats
    Takaoka, M
    Okamoto, H
    Ito, M
    Nishioka, M
    Kita, S
    Matsumura, Y
    LIFE SCIENCES, 1998, 63 (04) : PL65 - PL70
  • [47] NATRIURETIC AND ANTIHYPERTENSIVE EFFECTS OF POTASSIUM IN DOCA-SALT HYPERTENSIVE RATS
    FUJITA, T
    SATO, Y
    KIDNEY INTERNATIONAL, 1983, 24 (06) : 731 - 739
  • [48] EFFECTS OF ENDOTHELIN ON RESISTANCE ARTERIES OF DOCA-SALT HYPERTENSIVE RATS
    LI, Y
    SCHIFFRIN, EL
    AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (06): : H1782 - H1787
  • [49] Resveratrol prevents cardiovascular remodelling in DOCA-salt hypertensive rats
    Brown, Lindsay
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2006, 30 (09) : 84A - 84A
  • [50] 5-HT transporter (5-HTT) function is impaired in DOCA-salt hypertensive rats but not in spontaneously hypertensive rats (SHR)
    Ni, W
    Lookingland, K
    Watts, S
    HYPERTENSION, 2005, 46 (04) : 843 - 844